BeiGene Balance Sheet Health

Financial Health criteria checks 4/6

BeiGene has a total shareholder equity of $3.5B and total debt of $886.0M, which brings its debt-to-equity ratio to 25%. Its total assets and total liabilities are $5.8B and $2.3B respectively.

Key information

25.0%

Debt to equity ratio

US$885.98m

Debt

Interest coverage ration/a
CashUS$3.17b
EquityUS$3.54b
Total liabilitiesUS$2.27b
Total assetsUS$5.81b

Recent financial health updates

Recent updates

BeiGene Still Bleeding Red Ink Despite Blockbuster Drug

Mar 08

BeiGene, Ltd.'s (NASDAQ:BGNE) Intrinsic Value Is Potentially 26% Above Its Share Price

Jan 31
BeiGene, Ltd.'s (NASDAQ:BGNE) Intrinsic Value Is Potentially 26% Above Its Share Price

Here's Why BeiGene (NASDAQ:BGNE) Can Manage Its Debt Despite Losing Money

Oct 16
Here's Why BeiGene (NASDAQ:BGNE) Can Manage Its Debt Despite Losing Money

Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:BGNE) 39% Undervaluation?

Jul 11
Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:BGNE) 39% Undervaluation?

Rock star Growth Puts BeiGene (NASDAQ:BGNE) In A Position To Use Debt

Jun 19
Rock star Growth Puts BeiGene (NASDAQ:BGNE) In A Position To Use Debt

Revenues Not Telling The Story For BeiGene, Ltd. (NASDAQ:BGNE)

Apr 17
Revenues Not Telling The Story For BeiGene, Ltd. (NASDAQ:BGNE)

A Look At The Fair Value Of BeiGene, Ltd. (NASDAQ:BGNE)

Mar 24
A Look At The Fair Value Of BeiGene, Ltd. (NASDAQ:BGNE)

Is BeiGene (NASDAQ:BGNE) Using Debt Sensibly?

Dec 07
Is BeiGene (NASDAQ:BGNE) Using Debt Sensibly?

BeiGene upgraded to buy at Guggenheim on improved confidence in Brukinsa potential

Oct 13

EMA panel recommends extending indication for BeiGene's cancer drug Brukinsa

Sep 16

BeiGene, McKesson team up to develop data, tools for US community oncology care

Aug 15

Financial Position Analysis

Short Term Liabilities: BGNE's short term assets ($4.2B) exceed its short term liabilities ($1.8B).

Long Term Liabilities: BGNE's short term assets ($4.2B) exceed its long term liabilities ($457.8M).


Debt to Equity History and Analysis

Debt Level: BGNE has more cash than its total debt.

Reducing Debt: BGNE's debt to equity ratio has increased from 11.3% to 25% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BGNE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if BGNE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.